4//SEC Filing
Lamothe Jeffrey G. 4
Accession 0000950170-25-032197
CIK 0001671584other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 4:35 PM ET
Size
10.3 KB
Accession
0000950170-25-032197
Insider Transaction Report
Form 4
Lamothe Jeffrey G.
EVP, COO
Transactions
- Exercise/Conversion
Common Stock
2025-03-02+3→ 34 total - Exercise/Conversion
Restricted Stock Unit
2025-03-02−3→ 4 total→ Common Stock (3 underlying) - Exercise/Conversion
Common Stock
2025-03-03+2→ 36 total - Exercise/Conversion
Restricted Stock Unit
2025-03-03−2→ 0 total→ Common Stock (2 underlying)
Footnotes (3)
- [F1]Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
- [F2]On March 3, 2023, the reporting person was granted 16,500 (11 post-splits) RSUs, vesting in three approximately equal annual installments beginning on March 2, 2024.
- [F3]On June 7, 2022, the reporting person was granted 11,000 (7 post-splits) RSUs, vesting in three approximately equal annual installments beginning on March 3, 2023.
Documents
Issuer
Aptevo Therapeutics Inc.
CIK 0001671584
Entity typeother
Related Parties
1- filerCIK 0001679967
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 4:35 PM ET
- Size
- 10.3 KB